Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinaya Simha

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 6, 2021
Impaired Muscle Mitochondrial Function in Familial Partial LipodystrophyVinaya Simha, Ian R Lanza, Surendra Dasari, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2024
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical AdenomasRashi Sandooja, Jasmine Saini, Annop Kittithaworn, et al.
The New England Journal of Medicine|February 22, 2002
Leptin-replacement therapy for lipodystrophyElif Arioglu Oral, Vinaya Simha, Elaine Ruiz, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2025
Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: a Prospective Cohort StudyShireen R Chacko, Shubhangi Sharma Sharma, Sarina Ahmadian, et al.
BMJ Open|December 18, 2019
Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysisMohammed Yousufuddin, Paul Y Takahashi, Brittny Major, et al.
Journal of Clinical Lipidology|May 22, 2016
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trialPatrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
Mayo Clinic Proceedings|August 19, 2014
A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gapsFrancisco Lopez-Jimenez, Vinaya Simha, Randal J Thomas, et al.
European Heart Journal|August 31, 2016
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trialPatrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
The Journal of Clinical Investigation|November 4, 2025
A recurrent ACAA2 variant causes a dominant syndrome of lipodystrophy, lipomatosis, infantile steatohepatitis, and hypoglycemiaVinaya Simha, Mary Kate LoPiccolo, Anna Platt, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Phenotypic and genetic heterogeneity in congenital generalized lipodystrophyAnil K Agarwal, Vinaya Simha, Elif Arioglu Oral, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|October 6, 2021
Impaired Muscle Mitochondrial Function in Familial Partial LipodystrophyVinaya Simha, Ian R Lanza, Surendra Dasari, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2024
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical AdenomasRashi Sandooja, Jasmine Saini, Annop Kittithaworn, et al.
The New England Journal of Medicine|February 22, 2002
Leptin-replacement therapy for lipodystrophyElif Arioglu Oral, Vinaya Simha, Elaine Ruiz, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2025
Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: a Prospective Cohort StudyShireen R Chacko, Shubhangi Sharma Sharma, Sarina Ahmadian, et al.
BMJ Open|December 18, 2019
Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysisMohammed Yousufuddin, Paul Y Takahashi, Brittny Major, et al.
Journal of Clinical Lipidology|May 22, 2016
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trialPatrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
Mayo Clinic Proceedings|August 19, 2014
A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gapsFrancisco Lopez-Jimenez, Vinaya Simha, Randal J Thomas, et al.
European Heart Journal|August 31, 2016
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trialPatrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
The Journal of Clinical Investigation|November 4, 2025
A recurrent ACAA2 variant causes a dominant syndrome of lipodystrophy, lipomatosis, infantile steatohepatitis, and hypoglycemiaVinaya Simha, Mary Kate LoPiccolo, Anna Platt, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Phenotypic and genetic heterogeneity in congenital generalized lipodystrophyAnil K Agarwal, Vinaya Simha, Elif Arioglu Oral, et al.
Pageof 7